Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorbutol toxicity and dependence.

T Borody, P M Chinwah, G G Graham

    The Medical Journal of Australia
    |April 7, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.

    European journal of clinical pharmacology·2017
    Same author

    Trends in metformin utilisation and dose appropriateness in Australia.

    European journal of clinical pharmacology·2016
    Same author

    The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.

    Bone marrow transplantation·2016
    Same author

    Observation of B^{0}→pΛ[over ¯]D^{(*)-}.

    Physical review letters·2015
    Same author

    First Observation of the Hadronic Transition ϒ(4S)→ηh(b)(1P) and New Measurement of the h(b)(1P) and η(b)(1S) Parameters.

    Physical review letters·2015
    Same author

    First Observation of CP Violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} Decays by a Combined Time-Dependent Analysis of BABAR and Belle Data.

    Physical review letters·2015
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    Same journal

    Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

    The Medical journal of Australia·2026
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    See all related articles

    Chlorbutol toxicity and dependence were observed in a patient case. Its extremely long elimination half-life of 13.2 days indicates chlorbutol is an unsuitable sedative for public access.

    Area of Science:

    • Pharmacology
    • Toxicology
    • Clinical Medicine

    Background:

    • Chlorbutol, a sedative-hypnotic agent, has been historically available for medicinal use.
    • Concerns regarding the safety profile and potential for misuse of over-the-counter (OTC) medications are prevalent.
    • Understanding the pharmacokinetic properties of chlorbutol is crucial for assessing its clinical safety.

    Observation:

    • A clinical case involving a patient presenting with symptoms of chlorbutol toxicity and dependence is detailed.
    • The patient exhibited signs and symptoms consistent with prolonged exposure and adverse effects of chlorbutol.
    • Diagnostic evaluation focused on identifying the causative agent and assessing the extent of toxicity.

    Findings:

    • Pharmacokinetic analysis revealed an exceptionally long elimination half-life for chlorbutol, measured at 13.2 days in the affected patient.

    Related Experiment Videos

  • This prolonged half-life suggests a significant potential for drug accumulation with repeated exposure.
  • The findings indicate a substantial deviation from expected drug clearance rates.

    • Implications:

    • The extended elimination half-life strongly suggests that chlorbutol poses a significant risk of toxicity and dependence.
    • These findings support the conclusion that chlorbutol is an unsuitable sedative for unrestricted public availability.
    • Regulatory review and potential restrictions on chlorbutol access are warranted based on this evidence.